未批准的

Factors that could affect results include the ability to market and sell products; changes in relationships with strategic partners and reliance on strategic partners for the performance of critical activities under collaborative arrangements; failure of distributors or other customers to meet purchase forecasts or minimum purchase requirements for our products; impact of competitors, competing products and technology changes; ability to develop, commercialize and market new products; market acceptance of oral fluid testing or other new products or technology; changes in market acceptance based on product performance; continued bulk purchases by customers, including governmental agencies, and the ability to fully deploy those purchases in a timely manner; ability to fund research and development and other products and operations; ability to obtain and maintain new or existing product distribution channels; reliance on sole supply sources for critical product components; availability of related products produced by third parties; ability to obtain, and timing and cost of obtaining, necessary regulatory approval for new products or new indications or applications for existing products; ability to comply with applicable regulatory requirements; history of losses and ability to achieve sustained profitability; volatility of our stock price; uncertainty relating to patent protection and potential patent infringement claims; uncertainty and costs of litigation relating to patents and other intellectual property; availability of licenses to patents or other technology; ability to enter into international manufacturing agreements; obstacles to international marketing and manufacturing of products; ability to sell products internationally; loss or impairment of sources of capital; ability to meet financial covenants in agreements with financial institutions; ability to retain qualified personnel; exposure to product liability, patent infringement, and other types of litigation; changes in international, federal or state laws and regulations; customer consolidations and inventory practices; equipment failures and ability to obtain needed raw materials and components; the impact of terrorist attacks and civil unrest; ability to complete consolidation or restructuring activities; ability to identify, complete and realize the full benefits of potential acquisitions; and general political, business and economic conditions.

可能影响结果的因素包括营销以及出售产品的能力；与战略合作伙伴关系的变化以及根据合作协议对战略合作伙伴执行关键活动的依赖；经销商或者其他顾客未达到我方产品的采购预测或者最低采购要求；竞争对手、竞争产品以及技术变化的影响；新产品开发、商业化以及营销的能力；市场对唾液检测、其他新产品或者技术的接收程度、基于产品效果所造成的市场接收的变化；顾客、包括政府机构的持续大宗采购以及按时完成采购的能力；资助研究、开发以及其他产品和活动的能力；获得并维持新的或者现有的产品经销渠道的能力；关键产品部件对单一供应源的依赖；第三方生产的相关产品的供应情况；新产品或者现有产品的新疗效获得必要的管制批准的能力、时间以及费用；遵守适用的管制要求的能力；亏损的历史以及实现可持续盈利的能力；股票价格的波动；与专利保护和潜在的专利侵权诉讼有关的不确定性；与专利以及其他知识产权有关的不确定性以及诉讼费用；专利以及其他技术授权的提供情况；签订国际性制造协议的能力；产品进行国际营销以及制造的障碍；国际性销售产品的能力；资本来源的损失或者减少；履行与财务机构之间协议的能力；获得合格人员的能力；产品责任、专利侵权以及其他诉讼的风险；国际、联邦或者州的法律、法规的变化；顾客合并以及存货实践；设备故障以及获得所需原材料和部件的能力；恐怖主义袭击以及内乱的影响；完成合并或者重组活动的能力；识别、完成以及实现潜在收购的全部利益的能力；一般性政治、商业、经济形势等。

F post, publish, transmit, reproduce, distribute or in any way exploit any Information obtained through this Software for commercial purposes without our prior written permission unless otherwise specified by us in this Software or pursuant to separate licence granted by us

f 未得我们书面批准﹙除非我们在本软件中另有订明，或我们另外给予特许﹚而张贴、发布、传送、复制、分发或以任何方式利用从本软件获得的任何资料作商业用途

Actually, I have been liking you, is only you had not detected, when you tacitly approve to me you like her, I have how sadly.

实际上，我喜欢您，是只有您未查出，当您心照不宣地批准给您喜欢她时的我，我有多么哀伤地。

Offer for the grant of option The board is pleased to advise you that pursuant to a resolution passed at a meeting of the board held on 8th March 2007,the board has resolved to grant you the "Offer"(which is still subject to listing of committee of the stock exchange approving the granting of the listing of and permission to deal in the shares which may fall to be issued pursuant to the exercise of the options under the Pre-IPO Share Option Scheme) at a consideration of HK$1.00 an option pursuant to the Pre-IPO Share Option Scheme to subscribe for 40000 shares at an exercise price of 85% of final HK dollar price per share at which the shares are to be subscribed for /purchased and issued/ sold pursuant to the global offering of the shares in the initial public offering in or around March 2007 at any time during the six-year period commence from the expiry of twelve months from the listing dateprovided that the maximum number of shares in which you are entitled to subscribe for by exercising the option shall not exceed 25%of the total number of option shares during the period from expiry of the first anniversary of the listing date to the date immediately before the second anniversary of the listing date :and 25%of the total number of option shares during the period from expiry of the second anniversary of the listing date to the date immediately before the third anniversary of the listing date ;and 25%of the total number of option shares during the period from expiry of the third anniversary of the listing date to the date immediately before the fourth anniversary of the listing date ;and 25%of the total number of option shares during the period from expiry of the fourth anniversary of the listing date to the date immediately before the fifth anniversary of the listing date save that any of the outstanding and unexercised option at the end of each of the aforesaid vesting periods may be rolled over to the next vesting period and exercisable during the option period ,and the option shall,in any case ,lapse where you cease to be employed by the company or its subsidiaries for whatere reason or otherwise pursuant to the terms of the Pre-IPO Share Option Scheme.

登录后回答可以获得经验值奖励，并可以查看和管理所有的回答。登录|1.Offer的期权该委员会很高兴地通知您，根据是在对2007年3月8日举行的董事会会议上通过一项决议，该委员会决定授予您"要约"（依然受在联交所上市委员会批准给予上市，并准许其在交易的股票可能下跌发出依据根据首次公开招股前购股权计划之购股权获行使）在审议为港币1.00元的选择根据首次公开招股前购股权计划认购40000股为85港元，最终每股％美元的价格行使价格，股票要认购/购买并发行/出售依照全球发售的股份在最初在2007年3月左右上市期间的任何六年期开始从十二个月上市日期提供的届满时间，在你有权认购股份的最大数量行使在紧接上市日期2周年选项不得超过（在从上市日期一周年期间届满的日期一）25的选择权股份总数％：及在从该上市日期2周年期间届满之日起的25选择股份总数％，紧接上市三周年之日；25的选择权股份总数％，与从上市日期四周年期间届满的日期紧接上市日期五周年，并保存该悬而未决的和未执行的选择任何在最后上述的归属期间每年可结转到下一个归属期期间内行使的期权，而选择应在任何情况下，失误，你不再是由公司或whatere或其他原因及其附属公司雇用根据该条款前首次公开售股购股权Scheme。

Finally, the thesis will bring forward the strategies and suggestion of developing the industry, and as the following: firstly, enhance the well-bred breeding system of the main yellow-feather broiler as soon as possible from the inherit characteristics of broiler to Hong Kong; secondly, introduce advanced science and technology to reduce the ratio of feed consumed and meat and increase the economic benefit; thirdly, make the nutrition requirement of broiler standardization and the epidemic prevention system of poultry disease strengthen; fourthly, promote the enterprise to build the system of sincerity and trust to guarantee the quality of living chicken to Hong Kong; fifthly, make the management of veterinary medicine and quality supervising strengthen and forbid to use the contraband and unsanctified medicine and improve the system f rudimental medicine; sixthly, reinforce the hygiene and epidemic prevention in breeding room to improve the competition of living chicken in Hong Kong market; finally, introduce the system of HACCP, and carry out ISO9000 quality management system and ISO14000 environment management system, and adopt the advanced international way to manage the exported enterprises.

第八部分针对目前供港活鸡市场存在的问题，提出发展供港活鸡产业的策略和建议，包括：（1）从供港活鸡主要品种的遗传特性着手，尽快完善供港活鸡主要品种黄羽鸡的良种繁育体系；（2）引进先进的饲料科技技术降低料肉比以提高养禽经济效益；（3）规范肉食饲养的营养标准并加强禽病防疫体系的建设；（4）推动企业建立诚信制度，切实保供港活鸡产品的质量；（5）加强兽药管理和质量监管工作，禁止使用违禁药物和未被批准的药物并完善残留监控体系；（6）切实加强养殖场的卫生防疫工作，增强供港活鸡产品在香港市场的竞争力；（7）导入HACCP体系，尽可能推行ISO9000质量管理体系和ISO14000环境管理体系，以当前国际通行的先进方式管理禽肉出口企业。

The undisclosed problems with study 3014 led to a third review, during which FDA managers proposed using foreign postmarketing reports on Ketek as evidence of the product's safety, despite the unreliability of such data.2 Although drug sponsors are required to submit such reports as part of an application, it is extremely unusual to use these data to address critical preapproval safety issues in place of a controlled study.

3014研究中未揭露的问题带来了第三轮审查，FDA管理人员建议使用国外的Ketek售后报告作为产品安全性的证据，尽管这样的数据缺乏可信度。虽然要求药品赞助商提交这样的报告作为申请的一部分，但是却很少用这样的数据来替代对照研究对关键的批准前安全问题进行处理。

I am sorry to inform you that my application for a student assorts was disapprove d by the State Education Ministry.

我遗憾地通知您，我申请的学生护照未获国家教育部批准。

The term "bonded goods" means goods which have entered the territory, approved by the Customs as items for which no formalities are performed in the way of duty payment, and will be reshipped out of the territory after being stored, processed or assembled in the territory.

保税货物，是指经海关批准未办理纳税手续进境，在境内储存、加工、装配后复运出境的货物。

Where the approval documents are not obtained for the use of the shoreline of an established wharf, the owner of the wharf shall go through the approval formalities in accordance with the relevant provisions.

对于已建码头未取得岸线使用批准文件的，码头所有人应按有关规定补办批准手续。

The 19th article in the construction and production process of soil erosion caused by not govern, unable to control their own or take soil and water conservation program approved by the management of the unit or individual, should be assessed on its soil and water conservation program or a plan to control the cost of staging the Soil and water administration departments to pay fees to combat the loss of buried by soil and water conservation administrative department in charge of management of the organization.

第十九条在建设和生产过程中造成水土流失，不进行治理、无力自行治理或未接批准的水土保持方案进行治理的单位或个人，应按其水土保持方案的计划治理费用一次或分期向水土保持行政主管部门缴纳入土流失防治费，由水土保持行政主管部门组织治理。

This one mode pays close attention to network credence foundation of the businessman very much.

这一模式非常关注商人的网络信用基础。

Cell morphology of bacterial ghost of Pasteurella multocida was observed by scanning electron microscopy and inactivation ratio was estimated by CFU analysi.

扫描电镜观察多杀性巴氏杆菌细菌幽灵和菌落形成单位评价遗传灭活率。